Merck On A Mission To Introduce Automation To Fertility Treatment
Healthcare giant Merck is on a mission to introduce automation to fertility treatment and improve patient outcomes. The German company, already a leader in fertility drugs, aims to expand its market position by delivering innovative device technologies.
You may also be interested in...
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.